Core Insights - The medical device ETF (159873) has seen a significant increase in trading volume and net inflow, indicating strong investor interest and potential growth in the sector [1][2] Group 1: ETF Performance - As of January 30, 2026, the medical device ETF (159873) had a turnover rate of 6.47% with a transaction volume of 16.16 million yuan, while the tracked index (H30178) declined by 1.22% [1] - The latest size of the medical device ETF (159873) reached a one-year high, with a notable increase of 30 million shares over the past week [1] Group 2: Fund Inflows - Over the last 20 trading days, the medical device ETF (159873) experienced net inflows on 16 days, accumulating over 140 million yuan [2] Group 3: Product Highlights - The medical device ETF (159873) has a high concentration in brain-computer interface technology, accounting for over 17% of its holdings, with nearly 80% of its components from the Sci-Tech Innovation Board and the Growth Enterprise Market [2] - The ETF includes key players in the brain-computer interface sector such as Sanbo Brain Science, Xiangyu Medical, and Weisi Medical, which are expected to benefit from domestic innovation, accelerated exports, and new technologies [2] Group 4: Industry Events - On January 29, a demonstration of advanced brain-computer interface technology was held, showcasing how it can significantly improve the lives of individuals with disabilities [3] - The CEO of Qiangnao Technology presented a bionic hand that can be controlled intuitively without surgical implantation, highlighting the practical applications of brain-computer interfaces [3] Group 5: Institutional Perspectives - Donghai Securities noted that a recent policy from multiple government departments aims to transform the pharmaceutical retail industry from a "single drug sales" model to a "health service" model, encouraging mergers and acquisitions [4] - The policy is expected to enhance industry concentration and promote the development of comprehensive health services, including health consultations and elderly care [4]

Group 1: Market Growth and Foreign Investment - The Chinese market is attracting foreign investment due to its strong growth potential, with cargo imports expected to reach 18.5 trillion yuan by 2025 [1] - Over 70% of surveyed American companies in China are optimistic about market growth and do not plan to relocate their operations, with nearly 60% intending to increase investments in China [1] Group 2: Consumer Demand and Economic Contribution - The growth is driven by new consumer demands, with policies like the trade-in program benefiting over 360 million people and generating sales exceeding 2.6 trillion yuan [2] - By 2025, domestic demand is projected to contribute over 67% to economic growth, with consumption accounting for 52%, an increase of 5 percentage points from the previous year [2] Group 3: Industrial Structure and Innovation - The optimization of industrial structure is fostering innovation, with significant growth in high-tech manufacturing and equipment sectors, where the added value of high-tech manufacturing reached 17.1% of total industrial output [2] - The production of civil drones and industrial robots increased by 37.3% and 28% respectively compared to the previous year [2] Group 4: Private Sector and Economic Vitality - The private sector is a key driver of high-quality economic development, with private enterprises accounting for 57.3% of total import and export value, growing by 7.1% to 26.04 trillion yuan [4] - Policies supporting private enterprises and improving the business environment are expected to enhance economic vitality and competitiveness [4] Group 5: Global Trade Relations - China is expanding its global trade relations, engaging with 249 countries and regions, and becoming a major trading partner for over 160 countries [5] - More than 90% of surveyed multinational companies plan to continue investing in China, reflecting confidence in the Chinese economy [5]

近期发布的两则新闻，很值得关注。 一则是，2025年，中国货物进口规模再创新高，达18.5万亿元。另一则是中国美国商会发布的调查报告 显示，对中国市场增长持乐观态度的受访在华美企比例显著上升，七成以上企业不考虑转移在华业务， 近六成企业计划加大在华投资。在世界开放指数下滑、部分大宗商品国际市场价格下行的大背景下，中 国大市场的魅力凸显。 市场是当今世界最稀缺的资源。市场成长性越强，对全球资源越具有吸引力。中国市场正是凭借极强的 成长性，吸引外资布局中国。 成长性，得益于消费升级新需求。 时下，车厘子大量上市。不少消费者有这种感受：进口水果的价格更亲民了，实现"水果自由"的内涵更 丰富了。从欧洲的红酒、巧克力，到南美洲的肉类、鱼虾，再到大洋洲的乳品，全球好物纷至沓来，不 断满足人民美好生活需要。 经济体量大，向前发展需更强推动力。平均每天几千个发明专利诞生、4.5万辆新能源汽车下线、逾5亿 件快递包裹寄送……科技与产业深度融合，新旧动能有序转换，现代化产业体系向阳生长。因地制宜发 展新质生产力，持续为中国经济培育新优势。 成长性，得益于经营主体敢拼敢闯。 经营主体是推动经济高质量发展的活力源泉。外贸数据中，民营 ...

宏观层面，美国联邦储备委员会28日宣布维持联邦基金利率目标区间在3.5%至3.75%不变，但未来宽松 预期持续支撑市场情绪。叠加美元汇率持续走低，一度跌破96关口创四年新低，市场对贵金属及铜等优 质金属资产的需求不减，推动铜估值继续上探。美国劳工部周四公布数据显示，截至1月24日当周初请 失业金人数为20.9万人，虽高于预期的20.5万人，但低于前值修正后的21万人，显示裁员规模仍较低， 不过疲软的招聘态势加剧了家庭对劳动力市场的担忧。此外，美国总统特朗普称将于周五上午（北京时 间周五晚间）宣布美联储主席人选，市场高度关注，投机客做多情绪浓厚，继续主导铜价走势。 长江铜价copper.ccmn.cn短评：美指下跌、油价大涨引资金疯狂涌入做市，隔夜伦铜暴涨4.46%；多头获 利了结致沪期铜涨势收窄，但嘉能可铜产量骤降11%，预今现铜大涨。 【铜期货市场】美指下跌、油价大涨引资金疯狂涌入做市，隔夜伦铜偏强震荡，最新收盘报价13705美 元/吨，收涨585美元，涨幅4.46%，成交量75210手增加46339手，持仓量331270手增加1322手；晚间沪 铜高开跳涨突破新历史高度后回落，随后进入横盘区间震荡，主力月 ...

Core Viewpoint - The medical sector is showing signs of recovery in 2026, driven by policy clarity and the realization of innovative outcomes, leading to increased investment interest in medical ETFs [1][19]. Group 1: Current Core Logic and Positive Factors in the Medical Sector - The transition from "selling expectations" to "performance realization" is evident, with domestic medical device innovations gaining global recognition, thus becoming a new growth engine for the industry [3][21]. - The medical sector is experiencing a high proportion of companies meeting or exceeding their 2025 performance forecasts, indicating a favorable industry outlook [3][21]. - The recent surge in AI medical technologies is not just speculative but demonstrates clear cost-reduction and efficiency-enhancing capabilities in hospital operations and drug development [4][23]. Group 2: Policy Environment Changes - The policy environment has shifted from a "speed over quality" approach to one of "value co-creation," with recent signals indicating a more favorable stance on centralized procurement and medical insurance negotiations [6][24]. - Optimizations in the approval process for innovative medical devices and continuous improvements in procurement rules are expected to enhance the competitive landscape and restore profitability for companies [8][26]. - The introduction of a market exclusivity period in the revised Drug Administration Law is expected to boost long-term investment confidence in pharmaceutical R&D [9][27]. Group 3: Financial Support for Medical Equipment Updates - The national "two new" policy, focusing on large-scale equipment updates and consumer goods replacement, has allocated 62.5 billion yuan in special bonds to support medical equipment upgrades, benefiting listed companies in the medical device sector [10][28]. - There is a significant demand for replacing outdated medical equipment in domestic healthcare institutions, coupled with policies favoring domestic alternatives, leading to increased orders and market share for leading companies in imaging, surgical robots, and in-vitro diagnostics [10][28]. Group 4: Reasons for Recent Fund Inflows into Medical ETF (512170) - The medical ETF (512170) has seen substantial inflows, with a single-day capital increase of 499 million yuan on January 28, 2026, and a total of 1.8 billion yuan over nine consecutive trading days, reflecting a shift in market sentiment towards value recovery [1][19][14]. - The medical ETF is currently one of the largest medical-themed ETFs in A-shares, with a market size exceeding 26 billion yuan, driven by high cost-effectiveness and a consensus on bottom valuations [14][32]. - The ETF closely tracks the CSI Medical Index, with significant allocations in medical devices (53.17%) and medical services, making it an attractive option for both institutional and retail investors [14][32][34].

Group 1 - The core viewpoint of the news highlights the performance of the China Medical and Medical Device Innovation Index, with stocks showing mixed results, particularly noting the rise of Haizhi Science by 2.62% and the decline of Pian Zai Huang [1] - The Medical Innovation ETF has reached a new high in scale at 1.867 billion yuan, with significant net inflows totaling 186 million yuan over the past ten days, averaging 18.5756 million yuan daily [1] - The Ministry of Civil Affairs has issued guidelines to promote technological innovation in civil affairs, emphasizing the application of advanced technologies such as humanoid robots and brain-computer interfaces in various sectors including elderly care and rehabilitation [1] Group 2 - According to招商证券, brain-computer interface technology has transitioned from academic exploration to industrial application, with healthcare being the primary focus, accounting for 56% of global application scenarios [2] - The Chinese brain-computer interface industry is making significant progress in system integration and application, with its inclusion in the "14th Five-Year Plan" as one of the six future industries, indicating strong policy and local support [2] - The China Medical and Medical Device Innovation Index comprises 30 profitable and growth-oriented companies, with the top ten stocks accounting for 63.75% of the index [2]

Core Insights - The brain-computer interface (BCI) technology is at a critical industrial turning point, transitioning from academic exploration to commercial application, driven by policy and demand [1][4] - The medical field is the primary battlefield for BCI applications, accounting for 56% of the market, while non-medical sectors such as consumer, industrial, and education represent a combined 44%, indicating strong expansion potential [2][3] Industry Overview - BCI technology enables direct communication between the brain and external devices, facilitating bidirectional interaction from neural signals to control commands. The technology is categorized into invasive, semi-invasive, and non-invasive methods, with no absolute superiority among them; suitability depends on specific applications [1][3] - The global BCI market is projected to grow from $1.98 billion in 2023 to $7.63 billion by 2029, with China's market expected to reach 1.73 billion yuan in 2023, increasing its global share to 12.5% [2] Development Challenges - The BCI industry faces several challenges, including balancing high-throughput, high signal-to-noise ratio signal acquisition with long-term biocompatibility, and the need for breakthroughs in decoding algorithms and adaptive control precision [3] - Clinical challenges include the need for large-scale trials to verify the long-term safety and efficacy of invasive products, as well as the maturity of indication definitions, surgical standardization, and postoperative management systems [3] Global and Domestic Progress - The global BCI industry ecosystem is rapidly developing, with leading companies like Neuralink and Synchron innovating in high-throughput flexible implants and vascular interventions to enhance brain signal acquisition and interaction systems [4] - In China, significant progress has been made in system integration and application implementation, with a diverse enterprise matrix represented by companies such as Strong Brain Technology (non-invasive), Borui Kang (semi-invasive), and Xinwei Medical (interventional) [4] Relevant Companies - Key players in the primary market include Strong Brain Technology, Borui Kang, Ladder Medical, and others; in the secondary market, upstream companies like Maipu Medical and Meihao Medical, midstream companies like Xinwei Medical-B and Xiangyu Medical, and downstream companies like Sanbo Neuroscience are notable [5]

时下，车厘子大量上市。不少消费者有这种感受：进口水果的价格更亲民了，实现"水果自由"的内涵更 丰富了。从欧洲的红酒、巧克力，到南美洲的肉类、鱼虾，再到大洋洲的乳品，全球好物纷至沓来，不 断满足人民美好生活需要。 政策引领，促需求释放。去年，消费品以旧换新政策惠及超3.6亿人次，带动相关商品销售额超2.6万亿 元。2025年，内需对经济增长的贡献率超67%，其中消费贡献率达52%，比上年提高5个百分点。英国 《金融时报》刊文："不要低估中国消费者。" 成长性，得益于产业结构持续优化。 庞大需求激发创新创造。人工智能大模型加速奔跑，脑机接口迈向产业化，低空经济振翅高飞，回望 2025年，产业向新动能强。数据为证：规模以上装备制造业、高技术制造业增加值占规模以上工业增加 值的比重分别达到36.8%和17.1%，民用无人机、工业机器人产量分别比上年增长37.3%和28%。 市场成长性越强，对全球资源越具有吸引力。中国市场正是凭借极强的成长性，吸引外资布局中国 近期发布的两则新闻，很值得关注。 一则是，2025年，中国货物进口规模再创新高，达18.5万亿元。另一则是中国美国商会发布的调查报告 显示，对中国市场增长持乐观 ...

Core Viewpoint - The article discusses the integration of brain-machine interfaces (BMIs) and embodied intelligence in rehabilitation, highlighting the potential for these technologies to enhance patient recovery and redefine the roles of healthcare professionals and robots in medical settings [6][7][10]. Group 1: Brain-Machine Interface and Embodied Intelligence - The concept of combining BMIs with embodied intelligence is presented as a groundbreaking approach to rehabilitation, allowing robots to assist patients based on their brain signals [6][7]. - The integration of BMIs can potentially enable patients to control robotic devices through thought, enhancing the effectiveness of rehabilitation training [23][25]. - The article emphasizes that the future of rehabilitation may involve not only robots assisting doctors but also patients becoming "cyborgs" [8][10]. Group 2: Technological Advancements - Recent advancements in BMI technology, including lighter and more modular hardware, have made it feasible for large-scale deployment in clinical settings [31][36]. - The development of large models has improved the processing of complex brain signals, allowing for more accurate intention recognition [32][34]. - The article notes that the combination of these technological advancements has laid the groundwork for BMIs to actively participate in rehabilitation [35][36]. Group 3: Clinical Applications and Future Directions - Fourier's introduction of the "smart rehabilitation port" in 2020 has been a significant step in integrating advanced technologies into rehabilitation practices [11][12]. - The article outlines a strategic initiative to create a large-scale BMI data set to enhance the training of large models for better intention recognition [40][41]. - The potential for robots to serve as experimental platforms for understanding brain functions is highlighted, suggesting that they could facilitate research that is difficult to conduct directly on human subjects [64][65]. Group 4: Expert Insights and Discussions - Experts in the roundtable discussion emphasize the importance of leveraging intelligent devices to enhance the capabilities of healthcare professionals, rather than replacing them [49][56]. - The conversation also touches on the need for a comprehensive understanding of brain functions to improve the design of intelligent systems that can effectively interact with humans [51][62]. - The integration of BMIs, embodied intelligence, and AI is seen as a pathway to achieving significant advancements in both medical applications and broader societal impacts [60][63].

Domestic Financial Market - The National Development and Reform Commission is coordinating the development of charging infrastructure for new energy vehicles [5] - The Ministry of Civil Affairs is promoting the application of advanced technologies such as humanoid robots and brain-computer interfaces in the development of high-performance intelligent elderly care service robots [5] - The Ministry of Commerce is utilizing the China-US economic and trade consultation mechanism to manage differences and promote cooperation [5] Industry Latest Developments - Shenzhen is encouraging smart home systems to adapt to domestic systems and fully integrate AI, with related stocks including Ying Shi Innovation and Ruixin Microelectronics [7] - New gene therapy strategies are addressing the challenges of efficient delivery of long genes, with related stocks including Meibang Technology and Kaineng Health [7] - The surge in raw material prices and strong demand is leading to a price increase in electronic components, with related stocks including Jiang Hai Co. and Junwei Electronics [7] Focus on Listed Companies - Xinzhou Bang has submitted an application for listing on the Hong Kong Stock Exchange to strengthen its global supply layout for electronic chemicals [9] - Yunji Group plans to raise no more than 788 million yuan through a private placement to expand into intelligent manufacturing and overseas operations [9] - Lixing Co. intends to raise no more than 560 million yuan through a private placement to increase production capacity for high-end bearing rolling elements [9] - Bojie Co. is supplying liquid cooling testing equipment to N clients, with significant supply arrangements expected this year [9] Market Review and Outlook - On January 29, the three major indices showed mixed results, with the Shanghai Composite Index experiencing slight fluctuations and the Shanghai 50 Index rising over 1% [11] - The market saw rapid rotation of hotspots, with over 3,500 stocks declining, while the liquor sector surged in the afternoon [11] - The non-ferrous metals sector remained active, with copper and precious metals leading the gains, and the oil and gas sector continued its strong performance [11] - The real estate sector showed signs of rebound, while the chip industry faced declines [11] - Looking ahead, the market is expected to continue focusing on undervalued and high-certainty sectors, as the growth stocks are undergoing consolidation [11]